Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VCAM1 | P19320 | 3/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.58 |
| ▸ | MAPT | P10636 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 3/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | POLB | P06746 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | MERTK | Q12866 | 2/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.44 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.44 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.44 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.44 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2-Nitroaniline SCHEMBL7033834 | 0.92 | VCAM1 (0.55) | VCAM1TDP1MAPTMEN1KMT2A | |
| SCHEMBL7032441 | 0.87 | ALDH1A1 (0.50) | VCAM1TDP1MAPTMEN1KMT2A | |
| SCHEMBL7032412 | 0.87 | MAPT (0.50) | VCAM1TDP1MAPTMEN1KMT2A | |
| SCHEMBL31715931 | 0.85 | VCAM1 (0.59) | VCAM1TDP1MAPTMEN1KMT2A | |
| SCHEMBL1068675 | 0.85 | VCAM1 (0.59) | VCAM1TDP1MAPTMEN1KMT2A | |
| SCHEMBL27799226 | 0.83 | MAPT (0.60) | VCAM1TDP1MAPTMEN1KMT2A | |
| SCHEMBL5952203 | 0.82 | TDP1 (0.65) | VCAM1TDP1MAPTMEN1KMT2A | |
| SCHEMBL4477143 | 0.82 | VCAM1 (0.70) | VCAM1TDP1MAPTMEN1KMT2A | |
| SCHEMBL2394881 | 0.81 | MAPT (0.58) | VCAM1TDP1MAPTMEN1KMT2A | |
| SCHEMBL15156399 | 0.81 | MAPT (0.54) | VCAM1TDP1MAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 534 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114524770-B | Bis-benzimidazole fluorescent dye, preparation method and application thereof | 天津全和诚科技有限责任公司 | 2022-07-22 | — | — | CN | claimed |
| CN-114524770-A | Bis-benzimidazole fluorescent dye, preparation method and application thereof | 天津全和诚科技有限责任公司 | 2022-05-24 | — | — | CN | claimed |
| CN-113429394-A | Benzimidazole blue light material and preparation method and application thereof | 河南新中飞照明电子有限公司 | 2021-09-24 | — | — | CN | claimed |
| WO-2015022282-A1 | NITROGEN-DOPED CARBON NANOTUBES AS HIGH SELECTIVE NOBLE METAL-FREE CATALYSTS FOR HYDROGENATION OF FUNCTIONALIZED NITROAROMATICS | BAYER CROPSCIENCE AG (DE) | 2015-02-19 | — | — | WO | claimed |
| EP-2837612-A1 | Nitrogen-doped carbon nanotubes as high selective noble metal-free catalysts for hydrogenation of functionalized nitroaromatics | Bayer Technology Services GmbH (DE) | 2015-02-18 | — | — | EP | claimed |
| US-7547713-B2 | O-pyridinequinone derivatives, the composition containing the derivatives, the process for preparation of the derivatives and the use of the derivatives | GU LIANQUAN | 2009-06-16 | — | — | US | claimed |
| US-20060111405-A1 | O-pyridinequinone derivatives, the composition containing the derivatives, the process for preparation of the derivatives and the use of the derivatives | GU LIANQUAN | 2006-05-25 | — | — | US | claimed |
| EP-1590332-A1 | A PROCESS FOR THE SYNTHESIS OF BISBENZIMIDAZOLES AND ITS DERIVATIONS | University of Delhi (IN) | 2005-11-02 | — | — | EP | claimed |
| WO-2004063170-A1 | A PROCESS FOR THE SYNTHESIS OF BISBENZIMIDAZOLES AND ITS DERIVATIONS | UNIVERSITY OF DELHI (IN) | 2004-07-29 | — | — | WO | claimed |
| EP-0004606-B1 | PROCESS FOR PREPARING ANILINE COMPOUNDS | ETHYL CORPORATION (US) | 1982-03-10 | — | — | EP | claimed |
| US-12528827-B2 | Tricyclic heteroaryl-substituted quinoline and azaquinoline compounds as PAR4 inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2026-01-20 | — | — | US | disclosed |
| US-12433872-B2 | Treatment of Acanthamoeba or Balamuthia trophozoites and/or cysts | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2025-10-07 | — | — | US | disclosed |
| US-12331068-B2 | Compositions and methods for inhibiting CD73 | PELOTON THERAPEUTICS, INC. (US) | 2025-06-17 | — | — | US | disclosed |
| US-12275723-B2 | Compounds and uses thereof | JANSSEN PHARMACEUTICA NV (BE) | 2025-04-15 | — | — | US | disclosed |
| CN-119775792-A | Bio-based disazo lake pigment and preparation method thereof | 江苏丽王科技有限公司 | 2025-04-08 | — | — | CN | disclosed |
| US-4134723-A | DYEING AROMATIC POLYESTER/POLYAMIDE OR AROMATIC POLYESTER/CELLULOSE BLENDS WITH DISPERSE MONOAZO DYE, ALKALINE BATH | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1979-01-16 | — | — | US | disclosed |
| US-4118573-A | ANTIVIRAL AGENTS | ELI LILLY AND COMPANY (US) | 1978-10-03 | — | — | US | disclosed |
| US-4097450-A | REPAIRING NARROW CREVICE IN NICKEL-BASE SUPERALLOY | HOECHST AKTIENGESELLSCHAFT (DT) | 1978-06-27 | — | — | US | disclosed |
| US-4056523-A | SULFONAMIDO SUBSTITUTED | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-11-01 | — | — | US | disclosed |
| US-4018790-A | VIRICIDES | ELI LILLY AND COMPANY (US) | 1977-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060111405-A1 | O-pyridinequinone derivatives, the composition containing the derivatives, the process for preparation of the derivatives and the use of the derivatives | PTGS2, PTGES2, PTGES | VCAM1 4140/4885TDP1 3288/4885MAPT 3965/4885 |
| US-12275723-B2 | Compounds and uses thereof | NLN, ACHE, CLN6 | VCAM1 4243/4885TDP1 611/4885MAPT 22/4885 |
| US-12433872-B2 | Treatment of Acanthamoeba or Balamuthia trophozoites and/or cysts | PKD2, PKD1, MUC1 | VCAM1 2489/4885TDP1 4836/4885MAPT 3562/4885 |
| US-12331068-B2 | Compositions and methods for inhibiting CD73 | ENTPD5, NT5E, ENTPD1 | VCAM1 1109/4885TDP1 342/4885MAPT 4367/4885 |
| US-12528827-B2 | Tricyclic heteroaryl-substituted quinoline and azaquinoline compounds as PAR4 inhibitors | F2RL3, F2R, PF4 | VCAM1 455/4885TDP1 661/4885MAPT 4792/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.